Niagen Bioscience (NAGE) FCF Margin (2011 - 2026)
Niagen Bioscience (NAGE) reported FCF Margin of 3.99% for Q1 2026, down 2974.0% year-over-year from 0.14% in Q1 2025, and down 333.44% quarter-over-quarter from 1.71% in Q4 2025.
Niagen Bioscience (NAGE) FCF Margin (2011 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 14 years of FCF Margin data on file, last reported at 3.99% in Q1 2026.
- FCF Margin for Q1 2026 came in at 3.99%, down 2974.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 3.15% (down 1496.0% YoY), and the FY2025 annual result was 10.21%, down 179.0% from the prior year.
- FCF Margin retreated to 3.99% in Q1 2026 per NAGE's latest filing, from 1.71% in the prior quarter.
- Over five years, FCF Margin peaked at 29.23% in Q4 2024 and troughed at 41.85% in Q1 2022.
- A 5-year average of 1.39% and a median of 1.9% in 2023 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2023 and 2026: FCF Margin soared 5383 bps in 2023, then sank 2974 bps in 2026.
- A 5-year view of FCF Margin shows it stood at 2.38% in 2022, then soared by 224 bps to 2.96% in 2023, then jumped by 887 bps to 29.23% in 2024, then plunged by 94 bps to 1.71% in 2025, then plunged by 333 bps to 3.99% in 2026.
- Business Quant data shows NAGE's FCF Margin at 3.99% in Q1 2026, 1.71% in Q4 2025, and 10.89% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -3.98% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Niagen Bioscience | 280.11 Mn | 213.56 Mn | 19.98 Mn | -3.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.99% |
| Dec 31, 2025 | 1.71% |
| Sep 30, 2025 | 10.89% |
| Jun 30, 2025 | 3.48% |
| Mar 31, 2025 | 25.76% |
| Dec 31, 2024 | 29.23% |
| Sep 30, 2024 | 13.50% |
| Jun 30, 2024 | -1.21% |
| Mar 31, 2024 | 1.15% |
| Dec 31, 2023 | 2.96% |
| Sep 30, 2023 | 1.90% |
| Jun 30, 2023 | 16.09% |
| Mar 31, 2023 | 11.97% |
| Dec 31, 2022 | -2.38% |
| Sep 30, 2022 | -22.22% |
| Jun 30, 2022 | -23.41% |
| Mar 31, 2022 | -41.85% |
| Dec 31, 2021 | -27.85% |
| Sep 30, 2021 | -34.75% |
| Jun 30, 2021 | -46.10% |